Impact BioMedical Inc.
(IBO) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
1.85
-2.12%
After-hours Jan 07, 2025, 08:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
PE Ratio | -0.62 | -5.18 | -16 | -17 | -4.25 | n/a |
PS Ratio | 6.07 | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.65 | 6.80 | 19.95 | 8.46 | 5.88 | n/a |
P/FCF Ratio | -1.47 | -6.16 | -15.33 | -23.17 | -5.42 | n/a |
P/OCF Ratio | -1.5 | -6.16 | -15.52 | -23.17 | -5.42 | n/a |
OCF/S Ratio | -4.05 | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.44 | 0.14 | n/a | n/a | n/a | n/a |
Quick Ratio | 1.60 | 0.91 | 5.31 | 10.81 | 12.61 | 72.43 |
Current Ratio | 1.60 | 0.91 | 5.31 | 10.81 | 12.61 | 72.43 |
Asset Turnover | 0.17 | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | 7.34 | -255.45 | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -2.66 | -1.31 | -1.25 | -0.5 | -1.38 | n/a |
Return on Assets (ROA) | -1.66 | -0.97 | -1.01 | -0.45 | -1.27 | n/a |
Return on Capital (ROIC) | 0.09 | -1.28 | 0.00 | -0.17 | 0.22 | n/a |
Dividend Yield | n/a | 0.02 | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | -0.11 | n/a | n/a | n/a | n/a |
Gross Profit Margin | 1.00% | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -9.8% | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -9.8% | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | 0.46% | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |